System for production of helper dependent adenovirus vectors based on use of endonucleases
AssigneeAdVec, Inc.
InventorsFrank L. Graham, Philip Ng, Robin Parks, Silvia Bacchetti, Mauro Anglana
Life of this patent
Estimating the term…
Loading patent…
AssigneeAdVec, Inc.
InventorsFrank L. Graham, Philip Ng, Robin Parks, Silvia Bacchetti, Mauro Anglana
Estimating the term…
The present invention relates to methods for efficient and reliable construction of adenovirus vectors which contain and express foreign DNA and are useful for gene transfer into mammalian cells, for vaccines and for gene therapy. The invention provides for the growth and purification of adenovirus vectors (helper dependent vectors or HDVs) from which all or most of the viral genes have been removed. The vector system described herein is a new method designed to eliminate helper viruses from the final HDV preparation by cleavage of the helper virus DNA with an endonuclease, alone or in combination with other methods known to limit the level of helper virus contamination of helper dependent vector preparations. The disclosed methods and compositions also provide for regulated control of gene expression.
A helper adenovirus nucleic acid sequence comprising a packaging signal, an inserted endonuclease recognition site, a first inverted terminal repeat (ITR) located at one end of, and a second ITR located at the other end of, the nucleic acid sequence, and an embedded inverted terminal repeat (ITR), wherein:
A helper adenovirus nucleic acid sequence comprising a packaging signal, an endonuclease recognition site, a first inverted terminal repeat (ITR) located at one end of, and a second ITR located at the other end of, the nucleic acid sequence, and an embedded inverted terminal repeat (ITR), wherein:
A system for producing a helper dependent adenovirus vector comprising:
A method for making a helper dependent adenovirus vector preparation which comprises:
A method for achieving gene expression in a cell which comprises introducing into said cell an adenoviral vector preparation substantially free of helper adenovirus, wherein said adenoviral vector preparation is produced by a method which comprises:
Dependencies are inferred from the claim text.